KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Net Margin (2017 - 2025)

Guardant Health's Net Margin history spans 9 years, with the latest figure at 45.68% for Q4 2025.

  • For Q4 2025, Net Margin rose 932.0% year-over-year to 45.68%; the TTM value through Dec 2025 reached 42.39%, up 1666.0%, while the annual FY2025 figure was 42.39%, 1666.0% up from the prior year.
  • Net Margin for Q4 2025 was 45.68% at Guardant Health, down from 34.96% in the prior quarter.
  • Across five years, Net Margin topped out at 34.96% in Q3 2025 and bottomed at 210.21% in Q2 2022.
  • The 5-year median for Net Margin is 76.17% (2024), against an average of 88.76%.
  • The largest annual shift saw Net Margin plummeted -10427bps in 2022 before it soared 15715bps in 2023.
  • A 5-year view of Net Margin shows it stood at 84.09% in 2021, then crashed by -31bps to 110.28% in 2022, then dropped by -9bps to 120.63% in 2023, then surged by 54bps to 55.0% in 2024, then increased by 17bps to 45.68% in 2025.
  • Per Business Quant, the three most recent readings for GH's Net Margin are 45.68% (Q4 2025), 34.96% (Q3 2025), and 43.04% (Q2 2025).